Breakthrough Psoriasis in Patients Receiving Biologicals
Thomas Damsin, Gilles Absil, Florence Libon, Nazli Tassoudji, Arjen F Nikkels Department of Dermatology and Venerology, CHU of Sart Tilman, University of Liège B-4000, Liège, BelgiumCorrespondence: Arjen F Nikkels, Department of Dermatology and Venereology, CHU of Sart Tilman, University of Liège, B...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | Psoriasis: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/breakthrough-psoriasis-in-patients-receiving-biologicals-peer-reviewed-fulltext-article-PTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841558969553780736 |
|---|---|
| author | Damsin T Absil G Libon F Tassoudji N Nikkels AF |
| author_facet | Damsin T Absil G Libon F Tassoudji N Nikkels AF |
| author_sort | Damsin T |
| collection | DOAJ |
| description | Thomas Damsin, Gilles Absil, Florence Libon, Nazli Tassoudji, Arjen F Nikkels Department of Dermatology and Venerology, CHU of Sart Tilman, University of Liège B-4000, Liège, BelgiumCorrespondence: Arjen F Nikkels, Department of Dermatology and Venereology, CHU of Sart Tilman, University of Liège, B-4000, Liège, Belgium, Tel +32-43667232, Fax +32-43667234, Email af.nikkels@uliege.beBackground: Biological therapies, including TNF-alpha, IL12/23, IL17 and IL23 antagonists, adequately control a very high number of patients with moderate-to-severe psoriasis with an excellent long-term safety profile. However, on occasion, patients on biological therapy with stabilized disease or complete remission report episodes of sudden breakthrough psoriasis.Aim: To study prospectively in a monocentric tertiary setting, the clinical characteristics of patients presenting a sudden breakthrough psoriasis although completely stabilized (PASI 90– 100) under biological therapy.Materials and Methods: Psoriasis patients treated by biological therapies achieving PASI 90– 100 and with stabilized disease for at least 6 months were invited to enter the follow-up study for 5 years. The clinical features of patients presenting a breakthrough psoriasis were described as well as the rescue therapies and outcomes.Results: From the total cohort of 1121 patients with psoriasis receiving biologicals, 985 patients responded to the inclusion criteria. After 5 years, 10/882 cases (1,13%) of breakthrough psoriasis were identified. Two cases were induced by the Köbner phenomenon and 8 cases by severe psychological stress. Rescue therapies included topical very potent corticosteroids or additional injections of the biological. Two patients recovered spontaneously when the stressful event was resolved. In none of the cases, there was a consistency between the breakthrough event and the next scheduled injection, nor the duration of the exposure to the treatment. No biological class or agent could be systematically incriminated.Conclusion: Breakthrough psoriasis is an exceptional event among patients with stabilized psoriasis using biologicals, either triggered by the Köbner phenomenon or by severe psychological stress. The pathogenesis of the breakthrough events could be linked to stress- or Köbner-related immunomodulation, permitting breakthrough psoriasis lesions to appear.Keywords: psoriasis, biologicals, TNF-alpha, IL17, IL23, Köbner phenomenon, stress |
| format | Article |
| id | doaj-art-5d8461c7e88a41c4ba1ea6ae2ddf3293 |
| institution | Kabale University |
| issn | 2230-326X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Psoriasis: Targets and Therapy |
| spelling | doaj-art-5d8461c7e88a41c4ba1ea6ae2ddf32932025-01-05T16:36:04ZengDove Medical PressPsoriasis: Targets and Therapy2230-326X2025-01-01Volume 151898928Breakthrough Psoriasis in Patients Receiving BiologicalsDamsin TAbsil GLibon FTassoudji NNikkels AFThomas Damsin, Gilles Absil, Florence Libon, Nazli Tassoudji, Arjen F Nikkels Department of Dermatology and Venerology, CHU of Sart Tilman, University of Liège B-4000, Liège, BelgiumCorrespondence: Arjen F Nikkels, Department of Dermatology and Venereology, CHU of Sart Tilman, University of Liège, B-4000, Liège, Belgium, Tel +32-43667232, Fax +32-43667234, Email af.nikkels@uliege.beBackground: Biological therapies, including TNF-alpha, IL12/23, IL17 and IL23 antagonists, adequately control a very high number of patients with moderate-to-severe psoriasis with an excellent long-term safety profile. However, on occasion, patients on biological therapy with stabilized disease or complete remission report episodes of sudden breakthrough psoriasis.Aim: To study prospectively in a monocentric tertiary setting, the clinical characteristics of patients presenting a sudden breakthrough psoriasis although completely stabilized (PASI 90– 100) under biological therapy.Materials and Methods: Psoriasis patients treated by biological therapies achieving PASI 90– 100 and with stabilized disease for at least 6 months were invited to enter the follow-up study for 5 years. The clinical features of patients presenting a breakthrough psoriasis were described as well as the rescue therapies and outcomes.Results: From the total cohort of 1121 patients with psoriasis receiving biologicals, 985 patients responded to the inclusion criteria. After 5 years, 10/882 cases (1,13%) of breakthrough psoriasis were identified. Two cases were induced by the Köbner phenomenon and 8 cases by severe psychological stress. Rescue therapies included topical very potent corticosteroids or additional injections of the biological. Two patients recovered spontaneously when the stressful event was resolved. In none of the cases, there was a consistency between the breakthrough event and the next scheduled injection, nor the duration of the exposure to the treatment. No biological class or agent could be systematically incriminated.Conclusion: Breakthrough psoriasis is an exceptional event among patients with stabilized psoriasis using biologicals, either triggered by the Köbner phenomenon or by severe psychological stress. The pathogenesis of the breakthrough events could be linked to stress- or Köbner-related immunomodulation, permitting breakthrough psoriasis lesions to appear.Keywords: psoriasis, biologicals, TNF-alpha, IL17, IL23, Köbner phenomenon, stresshttps://www.dovepress.com/breakthrough-psoriasis-in-patients-receiving-biologicals-peer-reviewed-fulltext-article-PTTpsoriasisbiologicalstnf-alphail17il23köbner phenomenonstress |
| spellingShingle | Damsin T Absil G Libon F Tassoudji N Nikkels AF Breakthrough Psoriasis in Patients Receiving Biologicals Psoriasis: Targets and Therapy psoriasis biologicals tnf-alpha il17 il23 köbner phenomenon stress |
| title | Breakthrough Psoriasis in Patients Receiving Biologicals |
| title_full | Breakthrough Psoriasis in Patients Receiving Biologicals |
| title_fullStr | Breakthrough Psoriasis in Patients Receiving Biologicals |
| title_full_unstemmed | Breakthrough Psoriasis in Patients Receiving Biologicals |
| title_short | Breakthrough Psoriasis in Patients Receiving Biologicals |
| title_sort | breakthrough psoriasis in patients receiving biologicals |
| topic | psoriasis biologicals tnf-alpha il17 il23 köbner phenomenon stress |
| url | https://www.dovepress.com/breakthrough-psoriasis-in-patients-receiving-biologicals-peer-reviewed-fulltext-article-PTT |
| work_keys_str_mv | AT damsint breakthroughpsoriasisinpatientsreceivingbiologicals AT absilg breakthroughpsoriasisinpatientsreceivingbiologicals AT libonf breakthroughpsoriasisinpatientsreceivingbiologicals AT tassoudjin breakthroughpsoriasisinpatientsreceivingbiologicals AT nikkelsaf breakthroughpsoriasisinpatientsreceivingbiologicals |